Skip to main content
. 2022 Dec 19;95(1):e28393. doi: 10.1002/jmv.28393

Table 1.

Comparison of demographic characteristics and clinical data between two groups of study

Variables Total participants (n = 250) Intervention group (n = 125) Control group (n = 125) p Value
Gender Male (%) 138 (55.2) 64 (51.2) 74 (59.2) 0.203a
Female (%) 112 (44.8) 61 (48.8) 51 (40.8)
Age (year) Mean ± SD (Range) 55.01 ± 16.13 (18−90) 57.25 ± 15.80 (18−90) 52.77 ± 16.21 (24−89) 0.022 * , b
Median (IQR) 54 (41‐67) 56 (45−71) 53 (39−65)
Hight (cm) Mean ± SD (Range) 169.76 ± 10.24 (124−194) 169.53 ± 10.62 (150−194) 169.99 ± 9.88 (124−191) 0.548b
Median (IQR) 170 (161−178) 168 (160−179) 169.9 (162. 5−178)
Weight (kg) Mean ± SD (Range) 77.86 ± 17.08 (50–171) 76.72 ± 18.87 (50−171) 78.96 ± 15.08 (50−120) 0.112b
Median (IQR) 76 (67−86) 75 (64−85) 78 (67.5−87.5)
BMI Mean ± SD (Range) 27.07 ± 5.79 (16.79−60.55) 26.77 ± 6.63 (16.79−60.55) 27.37 ± 4.81 (19.53−43.57) 0.052b
Median (IQR) 26.19 (23.30−29.37) 25.05 (22.8−28.7) 26.66 (23.8−29.7)
Smoking status Yes (%) 19 (7.6) 10 (8) 9 (7.2) 0.811a
No (%) 231 (92.4) 115 (92) 116 (92.8)
Comorbidities Yes (%) 111 (44.4) 56 (44.8) 55 (44) 0.899a
No (%) 139 (55.6) 69 (55.2) 70 (56)
Comorbidity DM (%) 49 (19.6) 23 (18.4) 26 (20.8) 0.633a
types HTN (%) 63 (25.2) 29 (23.2) 34 (27.2) 0.466a
IHD (%) 26 (10.4) 14 (11.2) 12 (9.6) 0.679a
CKD (%) 20 (8.1) 8 (6.4) 12 (9.6) 0.351a
Cancer (%) 6 (2.3) 5 (4) 1 (0.8) 0.213c
Asthma (%) 8 (3.2) 6 (4.8) 2 (1.6) 0.281c
COPD (%) 4 (1.6) 3 (2.4) 1 (0.8) 0.622c
Hospital LOS Mean ± SD (Range) 11.89 ± 3.56 (7−37) 11.98 ± 3.61 (8−31) 11.81 ± 3.52 (7–37) 0.814b
Median (IQR) 11 (10−13) 11 (10−13) 12 (10−13)
ICU needed Yes (%) 23 (9.2) 9 (7.2) 14 (11.2) 0.274a
No (%) 227 (90.8) 116 (92.8) 111 (88.8)
Mortality Yes (%) 53 (21.2) 4 (3.2) 49 (39.2) <0.001 * , a
No (%) 197 (78.8) 121 (96.8) 76 (60.8)

Note: Bold values are statistically significant p values.

Abbreviations: CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; IHD, ischemic heart disease; HTN, hypertension.

a

p Value based on χ 2 test;

b

p Value based on Mann–Whitney u test;

c

p Value based on Fisher exact test;

*

p < 0.05 considered as significant.